Factor VII (FVII) deficiency, the most frequent defect among the rare bleeding disorders, is commonly divided into type I and type II. In the former, there is a concomitant decrease in FVII activity and antigen. In the latter, there is a clear discrepancy between activity which is low and antigen which is normal or nearly normal. FVII Padua (Arg304Gln) is characterized by different reactivity towards different tissue thromboplastins. FVII levels were assayed by the use of different tissue thromboplastins, namely rabbit brain, human placenta, human recombinant and ox brain thromboplastin, in 6 homozygous patients. Cases reported in the literature were also evaluated. Ox brain thromboplastins yielded normal values, whereas human tissue or recombinant human thromboplastins yielded only slightly higher levels of activity than those obtained with rabbit brain reagents. The ox brain versus rabbit brain ratio was about 22, whereas the ratio for human placenta or human recombinant versus rabbit brain thromboplastin was only about 5. The FVII antigen versus rabbit brain, human tissue and ox brain activity ratios were 24.8, 4.3 and 1.1, respectively. These results indicate that the ox brain versus the rabbit brain thromboplastin ratio supplies a wider difference than the one between human tissue and rabbit brain. The antigen/ox brain activity ratio of 1.1 fully confirms this assertion.

1.
Alexander B, Goldstein R, Landwehr G, Cook CD: Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J Clin Invest 1951;30:596–608.
2.
Perry DJ: Factor VII deficiency. Br J Haematol 2002;118:689–700.
3.
Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, Bosch N, Salazar-Sanchez L: Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia 2009;15:267–280.
4.
Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS: Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985;66:1284–1287.
5.
Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A: Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978;91:387–395.
6.
Girolami A, Patrassi G, Cappellato G, Casonato A: Another family with the factor VII Padua clotting defect. Acta Haematol 1979;62:4–11.
7.
Girolami A, Gaio A, Doglioni L, Procidano M, Saltarin P: Further studies on factor VII Padua defect: the report of the fourth homozygous patient from the same valley. Blut 1982;44:363–369.
8.
Girolami A, Dal Bo Zanon R, Caenazzo A, Scattolo N: Report of the fifth homozygous patient with factor VII Padua defect. Folia Haematol Int Mag Klin Morphol Blutforsch 1983;110:447–454.
9.
James HL, Kumar A, Girolami A, Hubbert J, Fair D: Variant coagulation Factor X and VII with point mutations in a highly conserved motif in the substrate binding pocket (abstract). Comparative molecular modelling. Thromb Hemost 1991;65:937.
10.
O’Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EG: Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991;78:132–140.
11.
Croze M, Brizard CP: Factor VII Padua 1. Another case. Haemostasis 1982;11:185–188.
12.
James HL, Girolami A, Hubbard JG, Kumar A, Fair DS: The dysfunction of coagulation factor VII Padua results from substitution of arginine-304 by glutamine. Biochim Biophys Acta 1993;1172:301–305.
13.
Peyvandi F, Jenkins PV, Mannucci PM, Billio A, Zeinali S, Perkins SJ, Perry DJ: Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Thromb Haemost 2000;84:250–257.
14.
Kernoff LM, Hughes J, Denson KW: Congenital factor VII deficiency. Clinical and laboratory characteristics of a newly discovered kindred. Clin Lab Haematol 1982;4:109–115.
15.
Girolami A, Dal Bo Zanon R, Zanella F, Procidano M, Ruffato G: Factor VII Padua defect: the heterozygote population. Acta Haematol 1982;68:34–38.
16.
Girolami A, Dal Bo Zanon R, Caenazzo A, Scattolo N: Report of the fifth homozygous patient with factor VII Padua defect. Folia Haematol 1983;110:447–454.
17.
Girolami A, Scandellari R, Scapin M, Vettore S: Congenital bleeding disorders of the vitamin K-dependent clotting factors. Vitam Horm 2008;78:281–374.
18.
Girolami A, Sartori MT, Steffan A, Fadin MA: Recombinant thromboplastin is slightly more sensitive to factor VII Padua than standard thromboplastins of human origin. Blood Coagul Fibrinolysis 1993;4:497–498.
19.
Fromovich-Amit Y, Zivelin A, Rosenberg N, Tamary H, Landau M, Seligsohn U: Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost 2004;2:1774–1781.
20.
Fromovich-Amit Y, Zivelin A, Rosenberg N, Landau M, Rosa JP, Seligsohn U: Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation. Blood Coagul Fibrinolysis 2005;16:369–374.
21.
Bernardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Redaelli R, Ballerini G, Pemberton S, Wacey AI, Mariani G, Tuddenham GB, Marchetti G: Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br J Haematol 1994;86:610–618.
22.
Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C, Jeanjean P, Igual H, Schved JF, Study Group of Factor Seven Deficiency: Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001;9:105–112.
23.
Takamiya O, McVey I, Kemhell-Cook G, Tuddenham E: Disfunctional human FVII variants and single-strand conformational polymorphism (SSC5) (abstract). Thromb Hemost 1993;69(suppl):1291.
24.
Tahatahary A, Ravanbod S, Baghaipour M, Enayar M, Ala F, Rastager-Iari: Factor VII genotype and clinical profile in 6 Iranian patients with congenital factor VII deficiency (abstract). J Thromb Hemost 2007;5(suppl):208.
25.
Sabharwal A, KuppusWarmy M, Foster D, Wildgoose P, Fisher L, Birktoft J, Bajaj S: Factor VII deficiency (FVII Richmond) associated with thrombosis (abstract). Circul 1992;88(suppl):679.
26.
Arbini AA, Bodkin D, Lopaciuk S, Bauer KA: Molecular analysis of Polish patients with factor VII deficiency. Blood 1994;84:2214–2220.
27.
Wulff K, Herrmann FH: Twenty two novel mutations of the factor VII gene in factor VII deficiency. Hum Mutat 2000;15:489–496.
28.
Mota L, Shetty S, Idicula-Thomas S, Ghosh K: Phenotypic and genotypic characterization of factor VII deficiency patients from Western India. Clin Chim Acta 2009;409:106–111.
29.
Rodrigues DN, Siqueira LH, Galizoni AM, Arruda VR, Annichino-Bizzacchi JM: Prevalence of factor VII deficiency and molecular characterization of the F7 gene in Brazilian patients. Blood Coagul Fibrinolysis 2003;14:289–292.
30.
Owren PA: The interrelationship between Normotest and Thrombotest. Farmakotherai 1969;25:1–13.
31.
Girolami A, Brunetti A, Patrassi GM: Normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon. Am J Clin Pathol 1977;67:57–60.
32.
Etro D, Pinotti M, Wulff K, Marchetti G, Rocino A, Herrmann FH, Bernardi F: The Gly331Ser mutation in factor VII in Europe and the Middle East. Haematologica 2003;88:1434–1436.
33.
Millar DS, Kemball-Cook G, McVey JH, Tuddenham EG, Mumford AD, Attock GB, Reverter JC, Lanir N, Parapia LA, Reynaud J, Meili E, von Felton A, Martinowitz U, Prangnell DR, Krawczak M, Cooper DN: Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet 2000;107:327–342.
34.
Takamiya O, Kimura S: Molecular mechanism of dysfunctional factor VII associated with the homozygous missense mutation 331Gly to Ser. Thromb Haemost 2005;93:414–419.
35.
Mariani G, Herrmann FH, Schulman S, Batorova A, Wulff K, Etro D, Dolce A, Auerswald G, Astermark J, Schved JF, Ingerslev J, Bernardi F, International Factor VII Deficiency Study Group: Thrombosis in inherited factor VII deficiency. J Thromb Haemost 2003;1:2153–2158.
36.
Stief TW, Wieczerzak A, Renz H: Influence of coagulation factors on extrinsic thrombin generation. Blood Coagul Fibrinolysis 2007;18:105–112.
37.
Matsushita T, Kojima T, Emi N, Takahashi I, Saito H: Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304→Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J Biol Chem 1994;269:7355–7363.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.